Unknown

Dataset Information

0

In vivo fluorescence imaging of gastrointestinal stromal tumors using fluorophore-conjugated anti-KIT antibody.


ABSTRACT: Gastrointestinal stromal tumors (GISTs) are frequently characterized by KIT overexpression. Tumor-free margins and complete cytoreduction of disease are mainstays of treatment. We hypothesized that fluorescently labeled anti-KIT antibodies can label GIST in vivo.KIT K641E(+/-) transgenic mice that spontaneously develop cecal GISTs were used in this study, with C57BL/6 mice serving as controls. Alexa 488 fluorophore-conjugated anti-KIT antibodies were delivered via the tail vein 24 h prior to fluorescence imaging. Following fluorescence laparoscopy, mice were sacrificed. The gastrointestinal tracts were grossly examined for tumors followed by fluorescence imaging. Tumors were harvested for histologic confirmation.KIT K641E(+/-) mice and C57BL/6 control mice received anti-KIT antibody or isotope control antibody. Fluorescence laparoscopy had a high tumor signal-to-background noise ratio. Upon blinded review of intravital fluorescence and bright light images, there were 2 false-positive and 0 false-negative results. The accuracy was 92 %. The sensitivity, specificity, positive and negative predictive values were 100, 87, 85, and 100 %, respectively, for the combined modalities.In this study, we present a method for in vivo fluorescence labeling of GIST in a murine model. Several translatable applications include: laparoscopic staging; visualization of peritoneal metastases; assessment of margin status; endoscopic differentiation of GISTs from other benign submucosal tumors; and longitudinal surveillance of disease response. This novel approach has clear clinical applications that warrant further research and development.

SUBMITTER: Metildi CA 

PROVIDER: S-EPMC4127988 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

In vivo fluorescence imaging of gastrointestinal stromal tumors using fluorophore-conjugated anti-KIT antibody.

Metildi Cristina A CA   Tang Chih-Min CM   Kaushal Sharmeela S   Leonard Stephanie Y SY   Magistri Paolo P   Tran Cao Hop S HS   Hoffman Robert M RM   Bouvet Michael M   Sicklick Jason K JK  

Annals of surgical oncology 20130814


<h4>Background</h4>Gastrointestinal stromal tumors (GISTs) are frequently characterized by KIT overexpression. Tumor-free margins and complete cytoreduction of disease are mainstays of treatment. We hypothesized that fluorescently labeled anti-KIT antibodies can label GIST in vivo.<h4>Methods</h4>KIT K641E(+/-) transgenic mice that spontaneously develop cecal GISTs were used in this study, with C57BL/6 mice serving as controls. Alexa 488 fluorophore-conjugated anti-KIT antibodies were delivered  ...[more]

Similar Datasets

| S-EPMC5928892 | biostudies-literature
| S-EPMC9744628 | biostudies-literature
| S-EPMC4118194 | biostudies-literature
| S-EPMC2912835 | biostudies-literature
| S-EPMC4462348 | biostudies-literature
| S-EPMC1876850 | biostudies-literature
| S-EPMC5058677 | biostudies-literature
| S-EPMC6756115 | biostudies-literature
| S-EPMC3587280 | biostudies-literature
| S-EPMC7713762 | biostudies-literature